Stock listing
Botanix Pharmaceuticals Limited
Selected listing: BOT · ASX · AUD · AU
Botanix Pharmaceuticals Limited (ASX:BOT), Health Technology. Latest release Sep 4, 2026: S&P DJI Announces September 2026 Quarterly Rebalance.
- Ticker
- ASX:BOT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- ASX
- Currency
- AUD
About Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited (BOT) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Botanix Pharmaceuticals Limited
S&P DJI Announces September 2026 Quarterly Rebalance
September 4, 2026
Appendix 4E & Annual Report for the Year Ended 30 June 2026
August 26, 2026
Botanix Quarterly Activities Report and Appendix 4C Q4 FY26
July 26, 2026
Notice of Allowance for US patent on Sofdra drug substance
July 12, 2026
Intention to Grant a European patent on Sofdra applicator
July 6, 2026
Events
Research Botanix Pharmaceuticals Limited
Botanix Pharmaceuticals Limited company profile
View the public company page for Botanix Pharmaceuticals Limited on 6ix.
Botanix Pharmaceuticals Limited news
Read company news and market updates connected to Botanix Pharmaceuticals Limited.
Botanix Pharmaceuticals Limited investor events
Find investor webinars, events, and replay context for Botanix Pharmaceuticals Limited.